I am a medical oncologist specializing in the care of patients with prostate cancer and other genitourinary malignancies. I work as part of a dedicated team including radiation oncologists and surgeons that adopts an individual approach to each patient’s care. As part of providing quality care to our patients, we offer innovative clinical trials that test new drugs and new imaging techniques in addition to standard cancer care options.
My clinical research interests are focused on providing access to new therapies to men with metastatic prostate cancer and those at high risk for recurrence. This includes therapies that target pathways we believe are important in prostate cancer as well as the use of biologics/immunotherapy.
I am also a member of the Immunotherapeutics Group at Memorial Sloan Kettering that works with patients with multiple types of cancer. As part of the team in the Immunotherapeutics Clinic (ITC), we design and conduct early clinical trials using investigational therapies that use the body’s own immune system to fight cancer.
- Clinical Expertise: Prostate Cancer; New Investigational Agents, including Immunotherapy
- Languages Spoken: English
- Education: MD, Stony Brook University Medical School; MSc, University of Virginia Department of Public Health Sciences
- Residencies: University of Virginia Hospital
- Fellowships: Memorial Sloan Kettering Cancer Center
- Board Certifications: Internal Medicine
Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more